In April 2026, Amneal Pharmaceuticals reported positive interim Phase 4 ELEVATE-PD data showing CREXONT delivered improved “Good On” time, reduced
Biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) will be reporting results this Monday after the bell. Here’s what investors should know.
We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) ranks 6th on
We just covered Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and Liquidia Corporation (NASDAQ:LQDA) ranks 1st on this
Jazz Pharmaceuticals (JAZZ) is back in focus after US regulators accepted a priority review of its supplemental biologics application for
Chugai Pharmaceutical Co., Ltd. reported first-quarter 2026 results with sales of ¥291,577 million, revenue of ¥321,747 million, and net income
AptarGroup (ATR) opened 2026 with Q1 revenue of US$982.9 million and basic EPS of US$1.13, while trailing twelve month revenue
After surging 119.70% so far in April, Organon & Co. (NYSE:OGN) secures a spot on our list of the mid-cap
Moderna Inc stocks today jumped big. MRNA shares in Nasdaq rose over six per cent in the pre-market on Friday.
Stock market news: Benchmark stock indices, Sensex and Nifty 50, finished almost 1% lower on Thursday as rising crude oil